Factors associated with subtherapeutic levels of oral posaconazole tablet: a detailed analysis from a tertiary care center in India

Factors associated with subtherapeutic levels of oral posaconazole tablet: a detailed analysis from a tertiary care center in India

Objectives: Posaconazole is a broad-spectrum triazole antifungal, with activity against various clinically important fungi. The delayed release (DR) tablet of posaconazole has been shown to have a superior pharmacokinetic profile in comparison with the oral suspension. Methods: We retrospectively an...

Full description

Bibliographic Details
Main Authors:	Parikshit S. Prayag, Shweta P. Panchakshari, Namita P. Mahalle, Surabhi Dhupad, Sampada A. Patwardhan, Sadanand S. Naik, Sharwari Narawade, Sameer Melinkeri, Amrita P. Prayag
Format:	Article
Language:	English
Published:	Elsevier 2022-11-01
Series:	International Journal of Infectious Diseases
Subjects:	Posaconazole Antifungal Infection
Online Access:	http://www.sciencedirect.com/science/article/pii/S1201971222005069

Similar Items

Pharmacokinetics and safety of posaconazole delayed-release tablets for invasive fungal infections
by: Wiederhold NP
Published: (2015-12-01)

Efficacy of combination therapy of amphotericin and posaconazole in treatment of mucormycosis
by: Sridhara S, et al.
Published: (2023-03-01)

Posaconazole as rescue therapy in African histoplasmosis
by: Daniel Gonçalves, et al.
Published: (2013-02-01)

Posaconazole as rescue therapy in African histoplasmosis
by: Daniel Gonçalves, et al.

Pharmacokinetic/pharmacodynamic study of posaconazole delayed-release tablet in a patient with coexisting invasive aspergillosis and mucormycosis
by: Leelawattanachai P, et al.
Published: (2019-04-01)

Posaconazole-induced Glucocorticoid Deficiency in a Patient with Myelodysplastic syndrome.
by: Antonia Precali, et al.
Published: (2023-01-01)

UV Spectrophotometric method for determination of posaconazole: comparison to HPLC
by: Andressa S. Bitencourt, et al.
Published: (2015-10-01)

The tablet formulation of posaconazole: clinical pharmacology and the use in patients with hematologic malignancies
by: Veselov A.V.
Published: (2020-05-01)

Posaconazole as single or adjunctive antifungal in mucormycosis of the maxilla: systematic review and meta-analysis
by: Pardiwala Arwa, et al.
Published: (2023-01-01)

Determination of Posaconazole in Plasma/Serum by High-Performance Liquid Chromatography with Fluorescence Detection
by: Peter H. Tang
Published: (2017-05-01)

Posaconazole: A Review of Drug Interactions with HIV Antiretroviral Agents
by: Mara Poulakos, et al.
Published: (2014-03-01)

Pharmaceutical co-crystals of posaconazole for improvement of physicochemical properties
by: Monika Nijhawan, et al.
Published: (2022-08-01)

Comparative pharmacoeconomic analysis of posaconazole therapy in tablet form and in suspension for invasive fungal infections prevention
by: I. S. Krysanov, et al.
Published: (2021-06-01)

Posaconazole‐induced hypertension in children with cystic fibrosis
by: Rachael Marpole, et al.
Published: (2021-09-01)

Evaluation of the role of itraconazole and posaconazole in viral infection as immunomodulatory drugs
by: Falah Hasan Obayes AL-Khikani
Published: (2021-01-01)

Interaction between posaconazole and flucloxacillin in a lung transplant patient: decrease in plasma exposure of posaconazole and possible undertreatment of invasive aspergillosis: case report
by: Saartje Verfaillie, et al.
Published: (2022-03-01)

Successful Treatment of Recurrent Cutaneous Purpureocillium lilacinum (Paecilomyces lilacinus) Infection with Posaconazole and Surgical Debridement
by: Wei-Yu Chen, et al.
Published: (2019-09-01)

Analysis of posaconazole as oral antifungal prophylaxis in pediatric patients under 12 years of age following allogeneic stem cell transplantation
by: Döring Michaela, et al.
Published: (2012-10-01)

Itraconazole and posaconazole from antifungal to antiviral drugs
by: Falah Hasan Obayes AL-Khikani
Published: (2022-01-01)

The Impact of Hypromellose on Pharmaceutical Properties of Alginate Microparticles as Novel Drug Carriers for Posaconazole
by: Katarzyna Kruk, et al.
Published: (2023-06-01)

Comparative evaluation of isavuconazonium sulfate, voriconazole, and posaconazole for the management of invasive fungal infections in an academic medical center
by: Edward T. Van Matre, et al.
Published: (2019-03-01)

Intravenous posaconazole: key features of clinical pharmacology and practical applications
by: A. V. Veselov, et al.
Published: (2022-04-01)

Successful treatment of pulmonary mucormycosis caused by Rhizopus microsporus with posaconazole
by: F. Yuan, et al.
Published: (2021-11-01)

Tratamiento antifúngico con posaconazol y anfotericina B en paciente con mucormicosis rinosinusal
by: MT Martínez-Lazcano, et al.
Published: (2015-04-01)

Tratamiento antifúngico con posaconazol y anfotericina B en paciente con mucormicosis rinosinusal
by: MT Martínez-Lazcano, et al.
Published: (2015-04-01)

New Drug Formulations of Posaconazole: Brief Clinical Pharmacology Review
by: Veselov A.V.
Published: (2016-11-01)

Voriconazole and posaconazole therapeutic drug monitoring: a retrospective study
by: Whitley M. Yi, et al.
Published: (2017-09-01)

Cutaneous alternariosis in a renal transplant patient successfully treated with posaconazole: Case report and literature review
by: Rajinder Bajwa, et al.
Published: (2017-03-01)

Severe Posaconazole-Induced Glucocorticoid Deficiency with Concurrent Pseudohyperaldosteronism: An Unfortunate Two-for-One Special
by: Alejandro Villar-Prados, et al.
Published: (2021-07-01)

A Review of Population Pharmacokinetic Models of Posaconazole
by: Ding Q, et al.
Published: (2022-10-01)

Successful treatment of allergic bronchopulmonary aspergillosis with posaconazole in a child with cystic fibrosis: Case report and review of the literature
by: Nurhayat Yakut, et al.
Published: (2020-01-01)

Formation and Characterisation of Posaconazole Hydrate Form
by: Michail Lykouras, et al.
Published: (2022-12-01)

Efficacy of the Benznidazole+Posaconazole combination therapy in parasitemia reduction: An experimental murine model of acute Chagas
by: Luis Eduardo Echeverría, et al.

Development of UPLC-MS/MS Method for Studying the Pharmacokinetic Interaction Between Dasatinib and Posaconazole in Rats
by: Yang S, et al.
Published: (2021-05-01)

External evaluation of published population pharmacokinetic models of posaconazole
by: Shuqi Huang, et al.
Published: (2022-09-01)

Polyelectrolyte-Complex-Based Hydrogel Inserts for Vaginal Delivery of Posaconazole and Probiotics
by: Sanjeevani Deshkar, et al.
Published: (2023-10-01)

Sample Preparation of Posaconazole Oral Suspensions for Identification of the Crystal Form of the Active Pharmaceutical Ingredient
by: Michail Lykouras, et al.
Published: (2020-12-01)

Dose Optimisation of Posaconazole and Therapeutic Drug Monitoring in Pediatric Patients
by: Mengmeng Jia, et al.
Published: (2022-04-01)

Synergistic effect of pyrvinium pamoate and posaconazole against Cryptococcus neoformans in vitro and in vivo
by: Yali Li, et al.
Published: (2022-12-01)

The Effect of Posaconazole and Isavuconazole on the Pharmacokinetics of Erdafitinib in Beagle Dogs by UPLC-MS/MS
by: Lan-hong Ruan, et al.
Published: (2021-11-01)